Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study

Authors

Institutions

Publication Details

Journal
BMC Women s Health
Published
2024-12-31
DOI
https://doi.org/10.1186/s12905-024-03526-w
Citations
1
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.28
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study

Haoyang Shen, Jiadi Li, Weizhu Wu, Shuixin Yan et al.
1 citations
BMC Women s Health
HER2/EGFR in Cancer Research
0.28
article

Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study

Haoyang Shen, Jiadi Li, Weizhu Wu, Shuixin Yan, Yu Qiu, Yan Chen
article en
1 citations

Abstract

No abstract available for this paper.
BMC Women s HealthVol. 24(1)
Ningbo University (CN), Ningbo Medical Center Lihuili Hospital (CN)
Good health and well-being
Openalex Percentile: Top 33%
HER2/EGFR in Cancer Research
0.28
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study — Haoyang Shen, Jiadi Li, et al. · BMC Women s Health (2024) | TGRS Research Map | TGRS